Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
8.96
+0.57 (6.79%)
At close: Nov 6, 2026, 4:00 PM EST
9.11
+0.14 (1.62%)
After-hours: Nov 6, 2026, 7:45 PM EST
Helus Pharma Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Helus Pharma stock has a consensus rating of "Strong Buy" and an average price target of $41.56. The average 1-year stock price forecast is 363.84% higher than the current stock price, while the lowest is $15.2 (+69.64%) and the highest is $70.59 (+687.83%).
Price Target: $41.56 (+363.84%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Helus Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $35 | Buy | Maintains | $35 | +290.62% | Nov 3, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $45 | Buy | Reiterates | $45 | +402.23% | Oct 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $42 | Buy | Reiterates | $42 | +368.75% | Oct 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +681.25% | Oct 22, 2026 |
| Jefferies | Jefferies | Buy Maintains $22 | Buy | Maintains | $22 | +145.54% | Oct 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
8.37M
EPS This Year
-2.90
from -4.18
EPS Next Year
-1.75
from -2.90
EPS and Forward PE are based on non-GAAP adjusted numbers.